Viewing Study NCT00487058


Ignite Creation Date: 2025-12-25 @ 12:04 AM
Ignite Modification Date: 2026-01-01 @ 5:04 PM
Study NCT ID: NCT00487058
Status: COMPLETED
Last Update Posted: 2009-11-19
First Post: 2007-06-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Dose Escalation Study of LBQ707 (Gimatecan) Administered Orally Twice Per Week to Japanese Patients With Advanced Solid Tumors
Sponsor: Novartis
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module